Overview


According to FutureWise analysis the market for antibody production in 2023 is US$ 18.50 billion, and is expected to reach US$ 49.59 billion by 2031 at a CAGR of 13.10%.

Antibody production is a fundamental process orchestrated by the immune system, primarily carried out by specialized B cells. The immune system's core function revolves around generating antibodies, a critical aspect of the body's defense mechanisms. These antibodies are vital players in immune responses, possessing a remarkable capability to specifically recognize and bind to foreign substances called antigens. These antigens can include various pathogens like bacteria or viruses. Once attached, antibodies facilitate the destruction or neutralization of these harmful entities. The term "antibody production" encompasses both general and specific implications. In a broad sense, it contains the entire sequence of steps involved in generating particular antibodies. This includes the preparatory processes of immunogen formulation, immunization, creating hybridoma cells (for monoclonal antibody production), screening for desired antibodies, and the final purification of the antibody.

Due to continuous advancements in antibody production techniques, various methods are now available. For instance, monoclonal antibodies can be efficiently produced using specialized hybridoma cells in controlled laboratories. On the other hand, polyclonal antibodies are typically manufactured in animals like rabbits.

FutureWise Market Research has published a report that provides an insightful analysis of Antibody Production Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts' projects that the Antibody Production Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Thermo Fisher Scientific, Inc.
  • GE Healthcare
  • Sartorius AG
  • Merck KGaA
  • Eppendorf AG
  • Cellab GmbH
  • Pall Corp.
  • INTEGRA Biosciences AG
  • FiberCell Systems Inc.

(Note: The list of the major players will be updated with the latest market scenario and trends)

Recent developments by key players in the Antibody Production Market:

  • In July 2022, GigaGen Inc., a subsidiary of Grifols, released a research paper in the esteemed Pathogens journal. The report highlighted their achievement in producing recombinant polyclonal antibodies under strict good manufacturing practices (GMP) standards. These antibodies target SARS-CoV-2 and are represented by the product GIGA-2050, which has undergone Investigational New Drug (IND)-enabling studies.

  • The National Institute of Health (NIH) in the United States initiated a clinical trial to assess the efficacy of dupilumab, a monoclonal antibody. This trial aims to determine its potential in reducing asthma attacks, enhancing lung function, and alleviating asthma symptoms in children struggling with poorly managed allergic asthma, particularly those residing in economically disadvantaged urban areas, in June 2022.

The antibody production market is experiencing significant growth driven by several key factors. Firstly, there is a surging demand for therapeutic antibodies due to the increasing prevalence of chronic diseases like cancer and autoimmune disorders. This has propelled the market forward as therapeutic antibodies become crucial components of treatment strategies. Additionally, continuous advancements in biotechnology and immunology have led to the development of more sophisticated antibody production techniques, expanding the market's capabilities. Moreover, the substantial investments made by pharmaceutical and biotechnology companies in research and development, particularly in the field of biologics and monoclonal antibodies, have contributed to the market's expansion. Furthermore, the growing applications of antibodies in diagnostic tools, such as ELISA and Western Blot, have been a driving force in the market's growth, particularly within the diagnostics segment. 

One significant restraint is the high cost and complexity associated with producing high-quality antibodies. This can be a barrier for smaller research labs or institutions with limited financial resources. Additionally, the process of antibody production is subject to stringent regulatory standards, which can lead to extended approval timelines and increased costs for manufacturers. Furthermore, the market faces competition from emerging technologies like gene editing and RNA therapeutics, which may divert attention and funding away from antibody-based therapies.

By Type

  • Polyclonal antibody
  • Monoclonal antibody
  • Murine
  • Chimeric
  • Humanized

By Process

  • Upstream processing
    • Bioreactors
      • Large-scale bioreactors
      • Single-use bioreactors
    • Consumables
      • Media
      • Buffers and reagents
  • Downstream processing
    • Chromatography systems
    • Chromatography resins
  • Filtration
    • Filtration systems
    • Filtration consumables and accessories

By End-Use

  • Pharmaceutical and biotechnology companies
  • Research laboratories
  • Others

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

This market research report also emphasis on factors affecting the growth rate in various regions listed above. A deep-down analysis of the region will also be provided in the final version of this market, which is based on the conclusion of primary interviews and secondary data points gathered during the process.

By region, the market is segmented into North America, Latin America, Europe, Asia-Pacific, and Middle East & Africa. North America registered the highest share in the market in 2022 due to the high prevalence of cancer, the strong presence of favourable healthcare infrastructure, and innovations and development of new products by the market players in this region. In addition, government initiatives for raising awareness and funds raised for research and development contribute to market growth.

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Antibody Production Market By Type, By Process, By End-Use and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction

    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders

  • 2.   Research Methodology

    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study

  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Antibody Production Market Variables, Trends and Scope

    •   1. Market LineProducts Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Antibody Production Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Antibody Production Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Antibody Production Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Polyclonal antibody
        2. Monoclonal antibody
        3. Murine
        4. Chimeric
        5. Humanized

  • 8.   Antibody Production Market, By Process Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Upstream processing
         1.1. Bioreactors
          1.1.1. Large-scale bioreactors
          1.1.2. Single-use bioreactors
         1.2. Consumables
          1.2.1. Media
          1.2.2. Buffers and reagents
        2. Downstream processing
         2.1. Chromatography systems
         2.2. Chromatography resins
        3. Filtration
         3.1. Filtration systems
         3.2. Filtration consumables and accessories

  • 9.   Antibody Production Market, By End-Use Historical Analysis and Forecast 2023-2031 (USD Million)

    •   1. Pharmaceutical and biotechnology companies
        2. Research laboratories
        3. Others

  • 10.   North America Antibody Production Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Antibody Production Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Antibody Production Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Antibody Production Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)

    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)

    •   1. Thermo Fisher Scientific, Inc.
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. GE Healthcare
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Sartorius AG
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Merck KGaA
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Eppendorf AG
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. INTEGRA Biosciences AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Cellab GmbH
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Pall Corp.
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. INTEGRA Biosciences AG
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. FiberCell Systems Inc.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client

Ask for Discount
Buy Now
Customize This Report
  • We Offer Special Discounts for start-ups, NGOs, and Educational & Research institutions.

Need Assistance

  • UK : +44 141 628 9353
  • US : +1 347 709 4931

What you get

  • Excel Dataset
  • Market Overview
  • Infographics
  • PowerPoint Presentation
  • PDF Report

What's included

  • Consumer Perception and Procurement
  • Market Data Forecast
  • Competitive Analysis
  • Risks and Opportunity Assessment
  • Market Trends and Dynamics
Partner

Our Clients

image0
image1
image2
image3
image4
image5
image6
image7
image8
image9
image10
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11
image11